Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients with ovarian cancer.
A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...
This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...
The Associated Press on MSN15d
Blood test for ovarian cancer misses some Black, Native American patients: StudyA new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
Sonnet BioTherapeutics (SONN) announced safety results of SON-1010 at the highest dose combined with atezolizumab in the Phase 1b/2a clinical ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results